NCT06656234 2024-10-24The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter StudyRuijin HospitalNot yet recruiting200 enrolled
NCT05968001 2023-08-01Obinutuzumab in Chinese Real-world Patients With iNHLAffiliated Hospital of Nantong UniversityNot yet recruiting400 enrolled
NCT05899621 2023-06-12A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FLRuijin HospitalRecruiting332 enrolled
NCT03374137 2023-01-12Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic LeukemiaHoffmann-La RocheCompleted55 enrolled
NCT02915224 2022-06-28A Study of Obinutuzumab Evaluating Efficacy, Safety and Cost of Disease Management in Participants With Chronic Lymphocytic Leukemia and ComorbiditiesHoffmann-La RocheCompleted50 enrolled
NCT03059251 2020-04-17Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in ArgentinaHoffmann-La RocheCompleted2 enrolled